chr16-89919505-T-C

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_002386.4(MC1R):​c.247T>C​(p.Ser83Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000542 in 1,613,152 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S83L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00053 ( 3 hom. )

Consequence

MC1R
NM_002386.4 missense

Scores

1
10
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:5

Conservation

PhyloP100: 2.63

Publications

29 publications found
Variant links:
Genes affected
MC1R (HGNC:6929): (melanocortin 1 receptor) This intronless gene encodes the receptor protein for melanocyte-stimulating hormone (MSH). The encoded protein, a seven pass transmembrane G protein coupled receptor, controls melanogenesis. Two types of melanin exist: red pheomelanin and black eumelanin. Gene mutations that lead to a loss in function are associated with increased pheomelanin production, which leads to lighter skin and hair color. Eumelanin is photoprotective but pheomelanin may contribute to UV-induced skin damage by generating free radicals upon UV radiation. Binding of MSH to its receptor activates the receptor and stimulates eumelanin synthesis. This receptor is a major determining factor in sun sensitivity and is a genetic risk factor for melanoma and non-melanoma skin cancer. Over 30 variant alleles have been identified which correlate with skin and hair color, providing evidence that this gene is an important component in determining normal human pigment variation. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009303957).
BP6
Variant 16-89919505-T-C is Benign according to our data. Variant chr16-89919505-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 321422.
BS2
High AC in GnomAd4 at 100 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MC1RNM_002386.4 linkc.247T>C p.Ser83Pro missense_variant Exon 1 of 1 ENST00000555147.2 NP_002377.4 Q01726Q1JUL4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MC1RENST00000555147.2 linkc.247T>C p.Ser83Pro missense_variant Exon 1 of 1 6 NM_002386.4 ENSP00000451605.1 Q01726
ENSG00000198211ENST00000556922.1 linkc.247T>C p.Ser83Pro missense_variant Exon 1 of 5 2 ENSP00000451560.1 A0A0B4J269
MC1RENST00000555427.1 linkc.247T>C p.Ser83Pro missense_variant Exon 3 of 4 5 ENSP00000451760.1 G3V4F0
MC1RENST00000639847.1 linkc.247T>C p.Ser83Pro missense_variant Exon 3 of 3 5 ENSP00000492011.1 Q01726

Frequencies

GnomAD3 genomes
AF:
0.000657
AC:
100
AN:
152202
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00196
Gnomad ASJ
AF:
0.0107
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000382
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00101
AC:
250
AN:
248738
AF XY:
0.00103
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00197
Gnomad ASJ exome
AF:
0.0121
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000409
Gnomad OTH exome
AF:
0.00248
GnomAD4 exome
AF:
0.000530
AC:
774
AN:
1460832
Hom.:
3
Cov.:
31
AF XY:
0.000550
AC XY:
400
AN XY:
726660
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00170
AC:
76
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.0128
AC:
334
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52702
Middle Eastern (MID)
AF:
0.00191
AC:
11
AN:
5766
European-Non Finnish (NFE)
AF:
0.000246
AC:
274
AN:
1111732
Other (OTH)
AF:
0.00129
AC:
78
AN:
60350
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
59
117
176
234
293
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000657
AC:
100
AN:
152320
Hom.:
0
Cov.:
33
AF XY:
0.000779
AC XY:
58
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.0000722
AC:
3
AN:
41576
American (AMR)
AF:
0.00196
AC:
30
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.0107
AC:
37
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000382
AC:
26
AN:
68020
Other (OTH)
AF:
0.00189
AC:
4
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00121
Hom.:
1
Bravo
AF:
0.000733
ESP6500AA
AF:
0.000228
AC:
1
ESP6500EA
AF:
0.00105
AC:
9
ExAC
AF:
0.000766
AC:
93
EpiCase
AF:
0.000763
EpiControl
AF:
0.000830

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:2
Mar 19, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MC1R: BP4 -

Sep 01, 2022
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 18, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Identified in either the homozygous state or with a second MC1R variant in an individual with pale skin and red hair, however, additional clinical and segregation information were not provided (PMID: 11933208); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34426522, 30531825, 35452484, 23647022, 38565069, 11933208, 19656326, 24335900) -

Melanoma, cutaneous malignant, susceptibility to, 5 Benign:2
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2 Uncertain:1
-
Institute of Human Genetics, University Hospital of Duesseldorf
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Tyrosinase-positive oculocutaneous albinism Benign:1
May 04, 2020
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.39
BayesDel_addAF
Benign
-0.094
T
BayesDel_noAF
Uncertain
0.090
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.68
.;D;D;.
Eigen
Uncertain
0.54
Eigen_PC
Uncertain
0.39
FATHMM_MKL
Benign
0.73
D
LIST_S2
Benign
0.55
T;.;T;T
M_CAP
Benign
0.025
D
MetaRNN
Benign
0.0093
T;T;T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Pathogenic
3.9
.;H;H;.
PhyloP100
2.6
PROVEAN
Uncertain
-3.3
D;.;D;N
REVEL
Uncertain
0.36
Sift
Uncertain
0.0010
D;.;D;D
Sift4G
Uncertain
0.012
D;.;D;D
Polyphen
1.0
.;D;D;.
Vest4
0.85
MVP
0.82
MPC
0.13
ClinPred
0.18
T
GERP RS
4.9
PromoterAI
-0.0064
Neutral
Varity_R
0.95
gMVP
0.79
Mutation Taster
=56/44
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34474212; hg19: chr16-89985913; API